[
  {
    "ts": null,
    "headline": "Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models",
    "summary": "WALTHAM, Mass., January 09, 2026--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating a scalable, federated framework designed to accelerate AI-enabled drug discovery.",
    "url": "https://finnhub.io/api/news?id=26d10b243c39f94bc681b0d9fa9aca02bc970bd0258e2fc05f557182bfa33443",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767963600,
      "headline": "Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models",
      "id": 138045461,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RVTY",
      "source": "Yahoo",
      "summary": "WALTHAM, Mass., January 09, 2026--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating a scalable, federated framework designed to accelerate AI-enabled drug discovery.",
      "url": "https://finnhub.io/api/news?id=26d10b243c39f94bc681b0d9fa9aca02bc970bd0258e2fc05f557182bfa33443"
    }
  }
]